Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$200.97 USD
-0.96 (-0.48%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $200.78 -0.19 (-0.09%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth B Momentum B VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 241 - 260 ( 386 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Potential Break Through in the Outsourced Drug Discovery Space
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
2020 Outlook: Healthcare IT / Digital Health and CRO / Biopharma Outsourcing
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
We reiterate our Overweight rating on CRL, and we are raising our growth outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department